"Hematologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Descriptor ID |
D019337
|
| MeSH Number(s) |
C04.588.448 C15.378.400
|
| Concept/Terms |
Hematologic Neoplasms- Hematologic Neoplasms
- Hematologic Malignancy
- Neoplasms, Hematologic
- Hematologic Neoplasm
- Neoplasm, Hematologic
- Hematological Neoplasms
- Hematological Neoplasm
- Neoplasm, Hematological
- Neoplasms, Hematological
- Malignancies, Hematologic
- Malignancy, Hematologic
- Hematologic Malignancies
- Hematological Malignancies
- Hematological Malignancy
- Malignancies, Hematological
- Malignancy, Hematological
Hematopoietic Neoplasms- Hematopoietic Neoplasms
- Neoplasms, Hematopoietic
- Hematopoietic Neoplasm
- Neoplasm, Hematopoietic
- Hematopoietic Malignancies
- Hematopoietic Malignancy
- Malignancies, Hematopoietic
- Malignancy, Hematopoietic
|
Below are MeSH descriptors whose meaning is more general than "Hematologic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Hematologic Neoplasms".
This graph shows the total number of publications written about "Hematologic Neoplasms" by people in this website by year, and whether "Hematologic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 3 | 1 | 4 |
| 2005 | 4 | 2 | 6 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 4 | 2 | 6 |
| 2009 | 1 | 1 | 2 |
| 2010 | 3 | 5 | 8 |
| 2011 | 7 | 0 | 7 |
| 2012 | 5 | 2 | 7 |
| 2013 | 6 | 1 | 7 |
| 2014 | 8 | 0 | 8 |
| 2015 | 17 | 3 | 20 |
| 2016 | 9 | 6 | 15 |
| 2017 | 4 | 1 | 5 |
| 2018 | 9 | 3 | 12 |
| 2019 | 9 | 1 | 10 |
| 2020 | 8 | 3 | 11 |
| 2021 | 8 | 2 | 10 |
| 2022 | 12 | 0 | 12 |
| 2023 | 12 | 0 | 12 |
| 2024 | 9 | 2 | 11 |
| 2025 | 6 | 0 | 6 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematologic Neoplasms" by people in Profiles.
-
Promises and potential pitfalls of in vivo CAR gene therapy. Blood. 2026 07 30; 148(5):535-544.
-
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation. J Clin Oncol. 2026 Aug 10; 44(23):2221-2232.
-
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee. Lancet Haematol. 2026 Jun; 13(6):e408-e417.
-
Association of infection frequency and incident clonal hematopoiesis of indeterminant potential. Exp Hematol. 2026 Jun; 158:105420.
-
Overcoming five main challenges to targeting hematologic malignancies. Cytotherapy. 2026 Aug; 28(8):102776.
-
Racial disparities in clonal hematopoiesis and their impact on hematologic malignancies. J Hematol Oncol. 2025 10 24; 18(1):88.
-
Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic Malignancy. J Pediatric Infect Dis Soc. 2025 Oct 02; 14(10).
-
Food for Thought: Addressing a Research Gap for Dietary Trials in Hematologic Malignancies. Blood Cancer Discov. 2025 09 03; 6(5):406-411.
-
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. Br J Haematol. 2025 Apr; 206(4):1109-1120.
-
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatr Blood Cancer. 2025 Apr; 72(4):e31557.